BURINI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 283
EU - Europa 124
AS - Asia 62
Continente sconosciuto - Info sul continente non disponibili 2
Totale 471
Nazione #
US - Stati Uniti d'America 282
CN - Cina 45
IT - Italia 42
PL - Polonia 19
GB - Regno Unito 17
UA - Ucraina 12
DE - Germania 11
TR - Turchia 11
SE - Svezia 8
BE - Belgio 7
FI - Finlandia 4
FR - Francia 3
EU - Europa 2
GE - Georgia 2
IR - Iran 2
VN - Vietnam 2
MX - Messico 1
NL - Olanda 1
Totale 471
Città #
Woodbridge 54
Fairfield 35
Chandler 27
Ann Arbor 25
Ferrara 24
Jacksonville 20
Houston 19
Warsaw 18
Seattle 16
Beijing 12
Ashburn 11
Wilmington 9
Guangzhou 6
Izmir 6
Nanjing 6
Cambridge 5
Dearborn 5
Milan 5
Boardman 4
Louvain 4
Princeton 4
Brussels 3
Reading 3
Shanghai 3
Sheffield 3
Shenyang 3
Bremen 2
Des Moines 2
Dong Ket 2
Hebei 2
Imola 2
Jiaxing 2
Nanchang 2
Portici 2
Amsterdam 1
Cento 1
Changchun 1
Changsha 1
Chengdu 1
Fars 1
Florence 1
Frankfurt am Main 1
Hangzhou 1
Huskvarna 1
Mexico 1
Norwalk 1
Quzhou 1
Rochester 1
San Diego 1
Wuhan 1
Zhengzhou 1
Totale 363
Nome #
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 145
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 122
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 120
null 93
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 9
Totale 489
Categoria #
all - tutte 1.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 0 14 19
2019/202085 16 3 2 11 7 14 7 10 8 3 3 1
2020/202199 5 4 4 4 13 8 4 12 5 14 15 11
2021/202238 3 4 2 0 4 2 0 1 2 3 2 15
2022/202358 5 7 3 9 14 4 4 3 5 2 0 2
2023/202419 2 5 1 0 2 2 1 6 0 0 0 0
Totale 489